Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.14
+0.62 (9.51%)
At close: Mar 9, 2026, 4:00 PM EDT
7.05
-0.09 (-1.26%)
Pre-market: Mar 10, 2026, 9:08 AM EDT

Edesa Biotech Revenue

Edesa Biotech had revenue of $102.43K in the quarter ending December 31, 2025, a decrease of -65.99%. This brings the company's revenue in the last twelve months to $585.12K, down -33.41% year-over-year. In the fiscal year ending September 30, 2025, Edesa Biotech had annual revenue of $783.89K with 12.26% growth.

Revenue (ttm)
$585.12K
Revenue Growth
-33.41%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
59.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2025783.89K85.62K12.26%
Sep 30, 2024698.28K117.24K20.18%
Sep 30, 2023581.04K-199.22K-25.53%
Sep 30, 2022780.26K-9.56M-92.45%
Sep 30, 202110.34M10.01M3,045.01%
Sep 30, 2020328.80K116.95K55.21%
Sep 30, 2018211.85K-16.44K-7.20%
Sep 30, 2017228.29K-1.04M-82.05%
Sep 30, 20161.27M513.00K67.62%
Sep 30, 2015758.69K386.56K103.88%
Aug 31, 2014372.13K-173.34K-31.78%
Aug 31, 2013545.47K259.42K90.69%
Aug 31, 2012286.05K-411.13K-58.97%
Aug 31, 2011697.19K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ImmuCell27.64M
Metagenomi Therapeutics25.21M
Alterity Therapeutics4.43M
NeurAxis3.36M
BeyondSpring1.88M
Entera Bio124.00K
eXoZymes-700.00
Revenue Rankings